Colgate-Palmolive remains a Buy, offering defensive qualities, a resilient global portfolio, and an attractive margin of ...
Two of the market’s most reliable dividend payers just cut checks to shareholders within days of each other. Procter & Gamble ...
Zacks Investment Research on MSN
Here's why Colgate-Palmolive (CL) is a strong growth stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Colgate-Palmolive stock (NYSE: CL) has gained 40% in value since early January 2023 – jumping from levels of around $75 then to over $105 now – vs. an increase of about 45% for the S&P 500 over this ...
A 15% year-to-date loss at a time when broader benchmarks are flirting with all-time highs may be enough to cause some investors to write off Colgate-Palmolive, but there are some sparks that could ...
Colgate-Palmolive serves global consumer markets across oral care, home care, personal care and pet nutrition within the S&P ...
Consumer goods manufacturer Colgate-Palmolive (NYSE:CL) reported mixed fourth-quarter and full-year 2024 earnings on Friday, Jan. 31. Adjusted earnings per share (EPS) for Q4 rose to $0.91, surpassing ...
Colgate-Palmolive India appoints former company veteran and Kenvue executive Manish Anandani as Managing Director and CEO as ...
With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results